At 24 months' follow-up, the only phase 3 randomized clinical trial to directly compare functional and oncologic outcomes between robot-assisted laparoscopic prostatectomy and open radical retropubic ...

Prostate cancer is the most common malignant tumor in men, accounting for 29% of male neoplasm diagnoses in the United States alone. Radical prostatectomy remains the preferred treatment for localized ...

With Men’s Health Week approaching, it is a good time to encourage open discussions about various health conditions, particularly prostate health. Driven by embarrassment, misconceptions, and a lack ...

Stereotactic body radiotherapy as salvage therapy after radical prostatectomy was well tolerated. Toxic effects were comparable to a historical cohort of patients receiving conventionally fractionated ...

Freedom from distant metastasis (FFDM) at 10 years was 93% with adjuvant RT and 90% with salvage treatment. After a median follow-up of 7.8 years, 52 patients in the adjuvant RT arm had died as ...

Dr. Robert Uzzo answers the question: 'Who Gets Robotic/Laparoscopic Surgery?' Jan. 01, 2009 -- Question: Who is an appropriate candidate for a laparoscopic or robot-assisted prostatectomy? Answer: ...

From 2004-2009 to 2016-2020, the proportion of patients found to have high-risk and intermediate-risk prostate cancer after upfront radical prostatectomy increased from 16% to 27% and from 55% to 60%, ...

Led by Prof Santosh Kumar, the urology team at Chandigarh’s PGIMER completes a marathon session of four robotic radical ...

Urologic surgeon Jose M. Flores, MD is lead author of a new study investigating the risk of biochemical recurrence after radical prostatectomy when taking ED drugs. There have been conflicting studies ...

Massey Comprehensive Cancer Center in Richmond is the first site in Virginia to offer a new non-surgical robotic ultrasound ...